Managing patients. Optimizing outcomes. Reducing costs.
AdherenceCameron® helps patients, or their healthcare providers, optimize drug therapy at a lower cost—with no decrease in quality of care. How? We monitor and improve medication use in patients with complex Medication Therapy Management. We achieve these goals by performing Comprehensive Medication Reviews (CMRs) and Targeted Intervention Programs (TIP®s).
Technology with a personal touch
Using technology already available in many households, AdherenceCameron’s patient-friendly Medication Therapy Management (MTM) pharmacists can review medication profiles and answer drug questions in real time using online interactive audiovisual tools.
Healthcare providers will see an improvement in patient adherence, elimination of duplicate medications, and a reduction in adverse drug interactions. And we provide drug information to both the patient and their healthcare team, improving communication and knowledge transfer.
Qualified, experienced professionals
The AdherenceCameron® pharmacists who provide Medication Therapy Management (MTM) or Adherence Services are all currently involved in clinical pharmacy practice, have recent clinical pharmacy experience, or have current or recent MTM experience. Many have their MTM Certification through the American Pharmacists Association (APhA) and other sources.
Improving adherence and outcomes
We seek to improve patient adherence, reduce the incidence of adverse drug interactions and/or events, and provide drug information to both the patient and their healthcare team. To make the MTM experience for these patients as convenient and comfortable as possible, we take the CMR to the patient.
Service in the comfort and convenience of their own home is preferred to making them go out to a pharmacy or a doctor’s office, or to another facility. Many of these patients are homebound or confined to bed and should not be inconvenienced by having to travel anywhere!
Take the next step.
Let AdherenceCameron® help. Call 800-532-0536 or contact us today.